首页 › 基金 › Michelson Medical Research Foundation, Inc. › IVE

Michelson Medical Research Foundation, Inc. 对 IVE 的持仓历史

ISHARES TR

Michelson Medical Research Foundation, Inc. 在 Q3 2026 的 13F 申报中披露持有 IVE(ISHARES TR)51,905 股,市值约 US$11.8M,约占其申报组合的 10.53%,在其申报持仓中市值排名第 2 位。 Michelson Medical Research Foundation, Inc. 最近 13 个申报季度中有 13 个季度披露了 IVE 持仓,最早可追溯至 Q3 2023。

最新持仓 (Q3 2026)51.91K 股
申报持仓市值$11.85M
组合权重10.53%
首次申报Q3 2023
最近变动持有
更新于2026-11-16

最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR

Michelson Medical Research Foundation, Inc. 对 IVE 的持仓演变

Michelson Medical Research Foundation, Inc. 于 Q3 2023 首次披露 IVE 持仓:51,905 股(约 US$8.0M)。 该持仓在 Q3 2026 达到峰值 51,905 股,市值约 US$11.8M。 在 13 次申报中,Michelson Medical Research Foundation, Inc. 的持股数量始终未变。 最近一期申报(Q3 2026)显示持股 51,905 股、市值约 US$11.8M。

逐季持仓明细

季度股数金额变化
Q3 2023 51.91K $7.99M 新进
Q4 2023 51.91K $9.03M 持有
Q1 2024 51.91K $9.70M 持有
Q2 2024 51.91K $9.45M 持有
Q3 2024 51.91K $10.23M 持有
Q4 2024 51.91K $9.91M 持有
Q1 2025 51.91K $9.89M 持有
Q2 2025 51.91K $10.14M 持有
Q3 2025 51.91K $10.72M 持有
Q4 2025 51.91K $11.01M 持有
Q1 2026 51.91K $10.96M 持有
Q2 2026 51.91K $11.79M 持有
Q3 2026 51.91K $11.85M 持有

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 IVE 与 13F 数据

IVE(ISHARES TR)的行业分类暂缺。我们追踪的基金中还有 26 只申报持有 IVE,申报仓位最大的包括:ENVESTNET ASSET MANAGEMENT INC (US$5.98B), 摩根大通 (US$3.65B), LPL Financial LLC (US$2.24B)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 IVE 的基金

查看 IVE 的全部基金持有人 →

常见问题

How long has Michelson Medical Research Foundation, Inc. held IVE?

Michelson Medical Research Foundation, Inc. has disclosed IVE holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Michelson Medical Research Foundation, Inc.'s current position in IVE?

As of Q3 2026, Michelson Medical Research Foundation, Inc. holds 51.91K shares of IVE (ISHARES TR), valued at $11.85M, representing 10.53% of its reported portfolio and ranking #2.

Has Michelson Medical Research Foundation, Inc. been buying or selling IVE?

In the latest 13F filing (Q3 2026), Michelson Medical Research Foundation, Inc. held unchanged its position in IVE. The position peaked in Q3 2026 at 51.91K shares.

Which other funds hold IVE?

Other major institutional holders of IVE include ENVESTNET ASSET MANAGEMENT INC, 摩根大通, LPL Financial LLC, among 26 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.